Amphion SPRL
The score of Amphion shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2003
Change 2000 → 2003: Revenue -48 % Equity +111 % Total assets -68 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Amphion's annual accounts
| 2003 | |
|---|---|
| Revenue | 170,538 € |
| Equity | 19,767 € |
| Cash | 91 € |
| Total assets | 76,657 € |
Amphion's financial analysis
- Solvency25.8%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Amphion
Amphion's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0454.733.525
- VAT number
- BE0454733525
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 03 Mar 1995
- Registered office
- 3300 Tienen
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Amphion (SPRL) has been based in Tienen since 1995, active in: manufacture of basic pharmaceutical products. For 2003, it reports revenue of 170,538 €, a net profit of — and equity of 19,767 €. Its solvency stands at 25.8%, below the median of its sector (56.0%).
Companies similar to Amphion
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Nuclear Fuel Experts Manufacture of basic pharmaceutical products Tervuren · balance sheet 137,815 €
- RheADC Manufacture of basic pharmaceutical products Leuven · balance sheet 31,395 €
- Pledge Therapeutics Manufacture of basic pharmaceutical products Leuven · balance sheet 229,854 €
- Clinical Research Vanackere Manufacture of basic pharmaceutical products Tielt-Winge · balance sheet 263,927 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- Kantoor Spapen Manufacture of basic pharmaceutical products Tienen · balance sheet 464,305 €
- P.V.E. - Technics Manufacture of basic pharmaceutical products Scherpenheuvel-Zichem · balance sheet 711,229 €
- Busco Manufacture of basic pharmaceutical products Tremelo · balance sheet 839,725 €
Frequently asked questions about Amphion
What is the revenue of Amphion?
According to the 2003 annual accounts filed with the NBB, the revenue of Amphion amounts to 170,538 €.
What is the VAT number of Amphion?
In Belgium, the VAT number is the company number prefixed with BE: BE0454733525 for Amphion, if the company is VAT-registered. Its company number (CBE) is 0454.733.525.
Where is the registered office of Amphion?
According to the CBE register, the registered office of Amphion is in 3300 Tienen.
What is the equity of Amphion?
At the close of the 2003 financial year, the equity of Amphion amounts to 19,767 €, a solvency of 25.8% of total assets.
Who manages Amphion?
The register lists 1 active mandates at Amphion. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Amphion
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →